Systemic Treatment of Thyroid Cancer: ASCO Guideline.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2026 Apr; JCO2600235. doi: 10.1200/JCO-26-00235. pii: .
Base: PUBMEDBrazilian Society of Surgical Oncology: Guidelines and Consensus Statement for Palliative Surgery in Oncology.
Journal of surgical oncology. 2026 Mar; 133(Mar):421-432. doi: 10.1002/jso.70189. pii: .
Base: PUBMEDMultiple Myeloma, Version 5.2026, NCCN Clinical Practice Guidelines In Oncology.
Journal of the National Comprehensive Cancer Network : JNCCN. 2026 Jan; 24(Jan):doi: 10.6004/jnccn.2026.0001. pii: e260001.
Base: PUBMEDT-Cell Immunity and Lung Cancer.
Respirology (Carlton, Vic.). 2026 Mar; 31(Mar):236-249. doi: 10.1002/resp.70220. pii: .
Base: PUBMEDLung cancer in women: current evidence and future research priorities.
Lung cancer (Amsterdam, Netherlands). 2026 Mar; 213(Mar):108905. doi: 10.1016/j.lungcan.2025.108905. pii: S0169-5002(25)00797-4.
Base: PUBMEDPerioperative Enfortumab Vedotin and Pembrolizumab in Bladder Cancer.
The New England journal of medicine. 2026 Apr; 394(Apr):1257-1269. doi: 10.1056/NEJMoa2511674. pii: .
Base: PUBMEDSurgical Quality Indicators for Locally Advanced Breast Carcinoma: Suggestions From the Brazilian Society of Surgical Oncology.
Journal of surgical oncology. 2026 Mar; 133(Mar):249-258. doi: 10.1002/jso.70159. pii: .
Base: PUBMEDApproach to the patient: Oncocytic thyroid cancer.
The Journal of clinical endocrinology and metabolism. 2026 Mar; 111(Mar):1159-1168. doi: 10.1210/clinem/dgag025. pii: .
Base: PUBMEDAssessing Colorectal Cancer and Mortality Risk in Older Adults.
JAMA. 2026 Apr; doi: 10.1001/jama.2026.2657. pii: .
Base: PUBMEDNeoadjuvant Therapies for Thyroid Cancer: A Scoping Review.
The Laryngoscope. 2026 Mar; doi: 10.1002/lary.70531. pii: .
Base: PUBMEDDual-targeting strategies for cancer and diabetes: Converging pharmacological pathways and repurposed therapies.
Molecular aspects of medicine. 2026 Mar; 109(Mar):101464. doi: 10.1016/j.mam.2026.101464. pii: S0098-2997(26)00020-8.
Base: PUBMEDThe Predictive Value of the Tumor-Stroma Ratio for Neoadjuvant Endocrine Therapy in Hormone Receptor-Positive Breast Cancer.
International journal of cancer. 2026 Apr; doi: 10.1002/ijc.70490. pii: .
Base: PUBMEDContrasting impacts of pretransplant cytoreduction and post-transplant maintenance on outcomes of allogeneic haematopoietic stem cell transplantation in myelodysplastic syndromes: Real-world multicentre evidence.
British journal of haematology. 2026 Apr; doi: 10.1111/bjh.70477. pii: .
Base: PUBMEDReal-World Outcomes in NPM1-Mutated Acute Myeloid Leukemia: The Impact of Measurable Residual Disease on Disease Relapse.
American journal of hematology. 2026 Apr; doi: 10.1002/ajh.70322. pii: .
Base: PUBMEDPredictors of complete molecular response and impact of allogeneic hematopoietic stem cell transplantation on outcome in patients with Philadelphia chromosome positive acute lymphoblastic leukemia (ALL): results from the Consortium on Myeloid Malignancies and Neoplastic Diseases (COMMAND).
Leukemia & lymphoma. 2026 Apr; 1-8. doi: 10.1080/10428194.2026.2650679. pii: .
Base: PUBMEDTargeted therapy in early-stage classical Hodgkin lymphoma.
Blood. 2026 Apr; 147(Apr):1655-1657. doi: 10.1182/blood.2025032560. pii: .
Base: PUBMEDConditioning for acute myeloid leukemia: looking beyond intensity.
Haematologica. 2026 Apr; doi: 10.3324/haematol.2026.300787. pii: .
Base: PUBMEDContemporary Multimodal Management of Primary Retroperitoneal Sarcomas.
Hematology/oncology clinics of North America. 2026 Feb; 40(Feb):155-164. doi: 10.1016/j.hoc.2025.07.012. pii: S0889-8588(25)00099-1.
Base: PUBMEDLung Cancer Risk in Preserved Ratio Impaired Spirometry and Airway Obstruction: A UK Biobank Study.
Chest. 2026 Mar; 169(Mar):837-848. doi: 10.1016/j.chest.2025.09.127. pii: S0012-3692(25)05501-1.
Base: PUBMEDA Narrative Review of the Efficacy of Acupuncture in Chemotherapy-Induced Peripheral Neuropathy in Cancer Patients.
Journal of evidence-based integrative medicine. 2026 ; 31():2515690X251411764. doi: 10.1177/2515690X251411764. pii: 2515690X251411764.
Base: PUBMEDSickle cell disease.
Lancet (London, England). 2026 Mar; 407(Mar):1095-1111. doi: 10.1016/S0140-6736(25)02278-0. pii: S0140-6736(25)02278-0.
Base: PUBMEDImmune Checkpoint Inhibitor-Induced Diabetes Across National Cancer Institute Trials That Included PD-1 or PD-L1 Agents.
JAMA oncology. 2026 Feb; 12(Feb):194-199. doi: 10.1001/jamaoncol.2025.5594. pii: .
Base: PUBMEDVascular Toxicities of Cancer Therapies: 2025 Update.
Arteriosclerosis, thrombosis, and vascular biology. 2026 Feb; 46(Feb):e319867. doi: 10.1161/ATVBAHA.125.319867. pii: .
Base: PUBMEDEfficacy of CD19 CAR T-cell therapy for patients with B-cell acute lymphoblastic leukemia relapsed after allogeneic transplantation.
Leukemia & lymphoma. 2026 Jan; 1-4. doi: 10.1080/10428194.2026.2619496. pii: .
Base: PUBMEDValacyclovir Treatment of Early Symptomatic Alzheimer Disease: The VALAD Randomized Clinical Trial.
JAMA. 2026 Feb; 335(Feb):511-522. doi: 10.1001/jama.2025.21738. pii: e2521738.
Base: PUBMEDNivolumab for Resected Stage III or IV Melanoma at 9 Years.
The New England journal of medicine. 2026 Jan; 394(Jan):333-342. doi: 10.1056/NEJMoa2504966. pii: .
Base: PUBMEDClinicopathologic Characteristics of Brain Metastasis of Pancreatic Ductal Adenocarcinoma.
The American journal of surgical pathology. 2026 Jan; 50(Jan):74-83. doi: 10.1097/PAS.0000000000002470. pii: .
Base: PUBMEDGlucagon-like peptide-1 medicines and cancer.
Nature cancer. 2026 Jan; doi: 10.1038/s43018-025-01110-1. pii: .
Base: PUBMEDAdult Cancer Pain, Version 2.2025, NCCN Clinical Practice Guidelines In Oncology.
Journal of the National Comprehensive Cancer Network : JNCCN. 2025 Jul; 23(Jul):doi: 10.6004/jnccn.2025.0032. pii: e250032.
Base: PUBMEDNCCN Guidelines® Insights: Thyroid Carcinoma, Version 1.2025.
Journal of the National Comprehensive Cancer Network : JNCCN. 2025 Jul; 23(Jul):doi: 10.6004/jnccn.2025.0033. pii: e250033.
Base: PUBMEDCutaneous melanoma: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up.
Annals of oncology : official journal of the European Society for Medical Oncology. 2025 Jan; 36(Jan):10-30. doi: 10.1016/j.annonc.2024.11.006. pii: S0923-7534(24)04912-3.
Base: PUBMEDAGO Breast Commission recommendations for the surgical therapy of breast cancer: Working Group on Gynecologic Cancers (AGO) update 2025.
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology. 2025 Nov; 51(Nov):110445. doi: 10.1016/j.ejso.2025.110445. pii: S0748-7983(25)00873-X.
Base: PUBMEDCancer in pregnancy: FIGO Best practice advice and narrative review.
International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics. 2025 Oct; 171(Oct):131-151. doi: 10.1002/ijgo.70258. pii: .
Base: PUBMEDGastrointestinal stromal tumour (GIST): British Sarcoma Group clinical practice guidelines.
British journal of cancer. 2025 Jan; 132(Jan):1-10. doi: 10.1038/s41416-024-02672-0. pii: .
Base: PUBMEDBritish Gynaecological Cancer Society (BGCS) ovarian, tubal and primary peritoneal cancer guidelines: Recommendations for practice update 2024.
European journal of obstetrics, gynecology, and reproductive biology. 2024 Sep; 300(Sep):69-123. doi: 10.1016/j.ejogrb.2024.06.025. pii: S0301-2115(24)00314-2.
Base: PUBMEDASO Practice Guidelines Series: Multidisciplinary Management of Retroperitoneal Sarcomas.
Annals of surgical oncology. 2025 Jul; 32(Jul):5343-5355. doi: 10.1245/s10434-025-17284-y. pii: .
Base: PUBMEDOpioid conversion in adults with cancer: MASCC-ASCO-AAHPM-HPNA-NICSO guideline.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer. 2025 Mar; 33(Mar):243. doi: 10.1007/s00520-025-09286-z. pii: .
Base: PUBMEDAASLD Practice Guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma.
Hepatology (Baltimore, Md.). 2023 Dec; 78(Dec):1922-1965. doi: 10.1097/HEP.0000000000000466. pii: .
Base: PUBMEDLung Cancer Screening and Incidental Findings: A Research Agenda: An Official American Thoracic Society Research Statement.
American journal of respiratory and critical care medicine. 2025 Mar; 211(Mar):436-451. doi: 10.1164/rccm.202501-0011ST. pii: .
Base: PUBMEDRadiotherapy in cutaneous lymphomas: Recommendations from the EORTC cutaneous lymphoma tumour group.
European journal of cancer (Oxford, England : 1990). 2024 Nov; 212(Nov):115064. doi: 10.1016/j.ejca.2024.115064. pii: S0959-8049(24)01030-X.
Base: PUBMEDAcute Lymphoblastic Leukemia, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology.
Journal of the National Comprehensive Cancer Network : JNCCN. 2024 Oct; 22(Oct):563-576. doi: 10.6004/jnccn.2024.0051. pii: .
Base: PUBMEDNCCN Guidelines® Insights: Ovarian Cancer/Fallopian Tube Cancer/Primary Peritoneal Cancer, Version 3.2024.
Journal of the National Comprehensive Cancer Network : JNCCN. 2024 Oct; 22(Oct):512-519. doi: 10.6004/jnccn.2024.0052. pii: .
Base: PUBMEDChallenges and opportunities for early phase clinical trials of novel drug-radiotherapy combinations: recommendations from NRG Oncology, the American Society for Radiation Oncology (ASTRO), the American College of Radiology (ACR), the Sarah Cannon Research Institute, and the American College of Radiation Oncology (ACRO).
The Lancet. Oncology. 2024 Oct; 25(Oct):e489-e500. doi: 10.1016/S1470-2045(24)00264-X. pii: S1470-2045(24)00264-X.
Base: PUBMEDManagement of Locally Advanced Rectal Cancer: ASCO Guideline.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2024 Oct; 42(Oct):3355-3375. doi: 10.1200/JCO.24.01160. pii: .
Base: PUBMEDA joint ESTRO and AAPM guideline for development, clinical validation and reporting of artificial intelligence models in radiation therapy.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology. 2024 Aug; 197(Aug):110345. doi: 10.1016/j.radonc.2024.110345. pii: S0167-8140(24)00615-7.
Base: PUBMEDEASL-ILCA Clinical Practice Guidelines on the management of intrahepatic cholangiocarcinoma.
Journal of hepatology. 2023 Jul; 79(Jul):181-208. doi: 10.1016/j.jhep.2023.03.010. pii: S0168-8278(23)00185-X.
Base: PUBMEDMultidisciplinary Treatment of Hepatocellular Carcinoma in 2023: Italian practice Treatment Guidelines of the Italian Association for the Study of the Liver (AISF), Italian Association of Medical Oncology (AIOM), Italian Association of Hepato-Bilio-Pancreatic Surgery (AICEP), Italian Association of Hospital Gastroenterologists (AIGO), Italian Association of Radiology and Clinical Oncology (AIRO), Italian Society of Pathological Anatomy and Diagnostic Cytology (SIAPeC-IAP), Italian Society of Surgery (SIC), Italian Society of Gastroenterology (SIGE), Italian Society of Medical and Interventional Radiology (SIRM), Italian Organ Transplant Society (SITO), and Association of Patients with Hepatitis and Liver Disease (EpaC) - Part I - Surgical treatments.
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver. 2024 Feb; 56(Feb):223-234. doi: 10.1016/j.dld.2023.10.029. pii: S1590-8658(23)01019-8.
Base: PUBMEDCannabis and Cannabinoids in Adults With Cancer: ASCO Guideline.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2024 May; 42(May):1575-1593. doi: 10.1200/JCO.23.02596. pii: .
Base: PUBMEDNCCN Guidelines® Insights: Rectal Cancer, Version 3.2024.
Journal of the National Comprehensive Cancer Network : JNCCN. 2024 Aug; 22(Aug):366-375. doi: 10.6004/jnccn.2024.0041. pii: .
Base: PUBMEDInternational Anal Neoplasia Society's consensus guidelines for anal cancer screening.
International journal of cancer. 2024 May; 154(May):1694-1702. doi: 10.1002/ijc.34850. pii: .
Base: PUBMEDEAU-EANM-ESTRO-ESUR-ISUP-SIOG Guidelines on Prostate Cancer-2024 Update. Part I: Screening, Diagnosis, and Local Treatment with Curative Intent.
European urology. 2024 Aug; 86(Aug):148-163. doi: 10.1016/j.eururo.2024.03.027. pii: S0302-2838(24)02254-1.
Base: PUBMED6th and 7th International consensus guidelines for the management of advanced breast cancer (ABC guidelines 6 and 7).
Breast (Edinburgh, Scotland). 2024 Aug; 76(Aug):103756. doi: 10.1016/j.breast.2024.103756. pii: 103756.
Base: PUBMEDBreast Cancer, Version 3.2024, NCCN Clinical Practice Guidelines in Oncology.
Journal of the National Comprehensive Cancer Network : JNCCN. 2024 Jul; 22(Jul):331-357. doi: 10.6004/jnccn.2024.0035. pii: .
Base: PUBMEDThe Predictive Value of the Tumor-Stroma Ratio for Neoadjuvant Endocrine Therapy in Hormone Receptor-Positive Breast Cancer.
International journal of cancer. 2026 Apr; doi: 10.1002/ijc.70490. pii: .
Base: PUBMEDContrasting impacts of pretransplant cytoreduction and post-transplant maintenance on outcomes of allogeneic haematopoietic stem cell transplantation in myelodysplastic syndromes: Real-world multicentre evidence.
British journal of haematology. 2026 Apr; doi: 10.1111/bjh.70477. pii: .
Base: PUBMEDReal-World Outcomes in NPM1-Mutated Acute Myeloid Leukemia: The Impact of Measurable Residual Disease on Disease Relapse.
American journal of hematology. 2026 Apr; doi: 10.1002/ajh.70322. pii: .
Base: PUBMEDPredictors of complete molecular response and impact of allogeneic hematopoietic stem cell transplantation on outcome in patients with Philadelphia chromosome positive acute lymphoblastic leukemia (ALL): results from the Consortium on Myeloid Malignancies and Neoplastic Diseases (COMMAND).
Leukemia & lymphoma. 2026 Apr; 1-8. doi: 10.1080/10428194.2026.2650679. pii: .
Base: PUBMEDConditioning for acute myeloid leukemia: looking beyond intensity.
Haematologica. 2026 Apr; doi: 10.3324/haematol.2026.300787. pii: .
Base: PUBMEDTargeted therapy in early-stage classical Hodgkin lymphoma.
Blood. 2026 Apr; 147(Apr):1655-1657. doi: 10.1182/blood.2025032560. pii: .
Base: PUBMEDAssessing Colorectal Cancer and Mortality Risk in Older Adults.
JAMA. 2026 Apr; doi: 10.1001/jama.2026.2657. pii: .
Base: PUBMEDSenescence in cancer: Hallmarks, paradoxes, and therapeutic promise.
Cell. 2026 Apr; doi: 10.1016/j.cell.2026.03.005. pii: S0092-8674(26)00272-2.
Base: PUBMEDPerioperative Enfortumab Vedotin and Pembrolizumab in Bladder Cancer.
The New England journal of medicine. 2026 Apr; 394(Apr):1257-1269. doi: 10.1056/NEJMoa2511674. pii: .
Base: PUBMEDSystemic Treatment of Thyroid Cancer: ASCO Guideline.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2026 Apr; JCO2600235. doi: 10.1200/JCO-26-00235. pii: .
Base: PUBMED